A recent study suggests that individuals who discontinue new weight-loss injections like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who halt traditional lifestyle programs.
Findings released in a prominent medical journal points out that while obese people often shed substantial amounts of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month once they quit.
"Users purchasing such drugs need to be informed of the potential of fast weight regain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery suggests a return to pre-treatment mass within about a year and a half.
Comparing Approaches
The research, which looked at 37 of studies involving thousands of patients, contrasted the results of GLP-1 agonists with older methods.
The team point out that people who shed pounds through diet and exercise usually see a slower creep back—perhaps 0.1 kg a month—once they finish.
Explaining the Fast Regain
Experts propose the mode of action of the jabs accounts for the accelerated weight return.
The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Stopping of this medication means hunger is no longer kept in check, making binge eating far more likely."
A Lifelong Issue?
Medical guidelines suggest the injections for people with weight-linked health risks, alongside recommended lifestyle changes.
A number of clinicians contend that, due to the significant potential of weight regain, the therapy might need to be life-long.
This view is echoed by pharmaceutical companies, who state that the findings "emphasize the persistent character of excess weight," similar to managing conditions like hypertension.
Patient Testimonies
Users who have come off the medication explain a powerful resurgence of appetite.
"It felt as if a trigger that goes on and you're instantly extremely hungry," described one woman.
This difficulty is compounded if individuals have not developed permanent dietary or behavioural changes during therapy.
Widespread Use
Recent estimates suggest that a significant number of people in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is greater among women than men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private healthcare rather than public health services.
In conclusion, experts stress that while these medications are powerful tools for shedding pounds, they are not a permanent fix and lasting health benefits hinges on integrated behavioural support.
